Dr. He Ting, CEO of Immunochina, was invited to participate in the 60th American Hematology Annual Meeting (ASH) 12-102018

Learn More

The joint laboratory of Immunochina and Sartorius is officially launched- this cooperation opened a new chapter in cell therapy 11-282018

Learn More

Immunochina was invited to participate in the "2018 China Research Hospital Association and China Disease Cell/Biotherapy Conference" 11-122018

Learn More

Immunochina won the 2018 Billboard • China's 50 Most Valuable Investment Enterprises 09-212018

Learn More

Immunochina CAR-T therapy for new indication’s submission was officially accepted by CFDA 08-082018

Learn More